Evidence map›Paper›PMID 30804375›Full record

ArticleScientific reports2019

Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems.

Beatrice Fortuni, Tomoko Inose, Monica Ricci, Yasuhiko Fujita, Indra Van Zundert, Akito Masuhara, Eduard Fron, Hideaki Mizuno, Loredana Latterini, Susana Rocha and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Phytogenic nanoparticles: synthesis, characterization, and their roles in physiology and biochemistry of plants.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Multivalent stimulation of βNanoscale advances · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Beatrice FortuniKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium. beatrice.fortuni@kuleuven.be.
Tomoko InoseRIES Hokkaido University, Research Institute for Electronic Science, N20W10, Kita-Ward Sapporo, 0010020, Japan.
Monica RicciKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium.
Yasuhiko FujitaToray Research Center, Inc., 3-3-7, Sonoyama, Otsu, Shiga, 520-8567, Japan.
Indra Van ZundertKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium.
Akito MasuharaYamagata University, department of Engineering, Yonezawa, Yamagata, 992-8510, Japan.
Eduard FronKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium.
Hideaki MizunoKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium.
Loredana LatteriniUniversity of Perugia, department of Chemistry, Biology and Biotechnology, via Elce di sotto 8, Perugia, Italy.
Susana RochaKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium. susana.rocha@kuleuven.be.
Hiroshi Uji-IKU Leuven, department of Chemistry, Celestijnenlaan 200G-F, Heverlee, 3001, Belgium. hiroshi.ujii@kuleuven.be.
KU Leuven · BEHokkaido University · JPToray Industries, Inc. (Japan) · JPUniversity of Perugia · ITYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most targeting strategies of anticancer drug delivery systems (DDSs) rely on the surface functionalization of nanocarriers with specific ligands, which trigger the internalization in cancer cells via receptor-mediated endocytosis. The endocytosis implies the entrapment of DDSs in acidic vesicles (endosomes and lysosomes) and their eventual ejection by exocytosis. This process, intrinsic to eukaryotic cells, is one of the main drawbacks of DDSs because it reduces the drug bioavailability in the intracellular environment. The escape of DDSs from the acidic vesicles is, therefore, crucial to enhance the therapeutic performance at low drug dose. To this end, we developed a multifunctionalized DDS that combines high specificity towards cancer cells with endosomal escape capabilities. Doxorubicin-loaded mesoporous silica nanoparticles were functionalized with polyethylenimine, a polymer commonly used to induce endosomal rupture, and hyaluronic acid, which binds to CD44 receptors, overexpressed in cancer cells. We show irrefutable proof that the developed DDS can escape the endosomal pathway upon polymeric functionalization. Interestingly, the combination of the two polymers resulted in higher endosomal escape efficiency than the polyethylenimine coating alone. Hyaluronic acid additionally provides the system with cancer targeting capability and enzymatically controlled drug release. Thanks to this multifunctionality, the engineered DDS had cytotoxicity comparable to the pure drug whilst displaying high specificity towards cancer cells. The polymeric engineering here developed enhances the performance of DDS at low drug dose, holding great potential for anticancer therapeutic applications.

Indexed as

Antibiotics, AntineoplasticCell SurvivalDoxorubicinDrug Delivery SystemsDrug LiberationEndocytosisEndosomesHumansHyaluronic AcidHydrogen-Ion ConcentrationNanoparticlesNeoplasmsParticle SizePolymersPorositySilicon DioxideAntibiotics, AntineoplasticDoxorubicinHyaluronic AcidPolymersSilicon Dioxide

Identifiers

PMID30804375
PMCPMC6389875
OpenAlexW2920648489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.